These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3972647)

  • 21. [Ginkgo extract EGb 761 (tenobin)/HAES versus naftidrofuryl (Dusodril)/HAES. A randomized study of therapy of sudden deafness].
    Hoffmann F; Beck C; Schutz A; Offermann P
    Laryngorhinootologie; 1994 Mar; 73(3):149-52. PubMed ID: 7513516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study on the use of urografin in the treatment of sudden deafness. Necessary preliminary study, results and review].
    Fiedler H
    HNO; 1984 Aug; 32(8):338-40. PubMed ID: 6480432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperbaric oxygen therapy in sudden deafness].
    Pilgramm M; Lamm H; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1985 Jul; 64(7):351-4. PubMed ID: 3875776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients.
    Zadeh MH; Storper IS; Spitzer JB
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):92-8. PubMed ID: 12574765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of sudden deafness with xantinolnicotinate (Complamin) in increasing dosage].
    Halevy A; Strohm G; Wieczorek U
    HNO; 1986 Jul; 34(7):285-90. PubMed ID: 3744912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.
    Ho HG; Lin HC; Shu MT; Yang CC; Tsai HT
    Laryngoscope; 2004 Jul; 114(7):1184-9. PubMed ID: 15235345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Idiopathic sudden sensorineural hearing loss. What's the appropriate management?].
    Ben Gamra O; Mbarek C; Ben Rejab I; Hariga I; Bhar H; Sghaier L; Zribi S; El Khedim A
    Tunis Med; 2007 Oct; 85(10):839-42. PubMed ID: 18236805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of sudden hearing loss].
    Russolo M; Bianchi M
    Acta Otorhinolaryngol Ital; 1997 Oct; 17(5):319-24. PubMed ID: 9549118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperbaric oxygen as a method of therapy of sudden sensorineural hearing loss.
    Racić G; Petri NM; Andrić D
    Int Marit Health; 2001; 52(1-4):74-84. PubMed ID: 11817844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical analysis of psychogenic sudden deafness.
    Ban JH; Jin SM
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):970-4. PubMed ID: 16730540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E1 in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
    Suzuki H; Fujimura T; Ikeda K; Shiomori T; Udaka T; Ohbuchi T; Nagatani G
    Acta Otolaryngol; 2008 Jan; 128(1):61-5. PubMed ID: 17851957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary clinical study of application of cyntridini triphosphatis and dexamethasone in treatment of sudden deafness].
    Luo W; Liu S; Liang C; Liu Y; Zhou C; Cao Q; Su J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Aug; 37(4):277-9. PubMed ID: 12772414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.
    Klemm E; Bepperling F; Burschka MA; Mösges R;
    Otol Neurotol; 2007 Feb; 28(2):157-70. PubMed ID: 17255882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical associations of serum antiendothelial cell antibodies in patients with sudden sensorineural hearing loss.
    Cadoni G; Agostino S; Manna R; De Santis A; Fetoni AR; Vulpiani P; Ottaviani F
    Laryngoscope; 2003 May; 113(5):797-801. PubMed ID: 12792313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and electron microscopy study of sudden deafness treatment with the 10% HES 200/0.5 and pentoxifylline combination].
    Leunig A; Szeimies RM; Wilmes E; Gutmann R; Stolz W; Feyh J
    Laryngorhinootologie; 1995 Mar; 74(3):135-40. PubMed ID: 7538765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sudden deafness: stepwise regression analysis on the correlation factors with prognosis].
    Gu Z; Tong L; Sun K
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Apr; 32(2):81-3. PubMed ID: 10743133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.
    Kakehata S; Sasaki A; Oji K; Futai K; Ota S; Makinae K; Shinkawa H
    Otol Neurotol; 2006 Aug; 27(5):604-8. PubMed ID: 16788418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allergic reaction in therapy with naftidrofuryl (Dusodril). A case report].
    Matschke RG
    HNO; 1987 May; 35(5):219-21. PubMed ID: 3610682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.